Qkine
PrivateLast Round
VC Round
Mar 21, 2025
Total Funding Raised
$3.15M
Company Overview
Qkine is a biotechnology company that manufactures high-purity, animal-free growth factors, cytokines, and other complex proteins for life science applications, including stem cell and organoid culture.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qkine Comparables
Compare Qkine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ORF Genetics | 81% | |
| Core Biogenesis | 80% | |
| Akron Biotech | 78% |
Qkine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 21, 2025 | ||||
| Debt | Dec 19, 2022 | ||||
| VC Round | Dec 15, 2022 | ||||
| Series A | Jun 8, 2020 | ||||
| Seed | Jun 3, 2019 | ||||
Seed | Apr 23, 2018 |
Qkine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Debt |
| o2h ventures | VC Round |
| Cambridge Enterprise | Seed, Series A |
| Downing Ventures | VC Round |
| Parkwalk Advisors | VC Round, Series A |
| Oxford Innovation Finance | VC Round |
| Martlet Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
Launched QkPlate (C), pre-prepared dried vitronectin-coated plates.
- Mar 23, 2026
Developing QkPlate (C) human vitronectin coated plates.
Recent news
Latest coverage and updates
- partners_withJun 22, 2026
Qkine Ltd partnered with Defined Bioscience, Inc. on May 1st '26.
Qkine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Qkine's valuation, stock price, and market status.
Is Qkine a public or private company?
Qkine is a private company.
What is the current stock price of Qkine?
Qkine is a private company with no public stock price. No recent secondary market data is available.
How much is Qkine worth (valuation)?
Valuation information for Qkine is not publicly available.
Can I buy Qkine stock?
Qkine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Qkine's last funding round?
Qkine's most recent funding round was Debt on December 19, 2022.
Who are the main investors in Qkine?
Key investors in Qkine include Cambridge Enterprise, Downing Ventures, Parkwalk Advisors.
Will Qkine IPO soon?
No public IPO plans have been announced for Qkine.
How can I track Qkine secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Qkine's secondary market activity and sign up for updates.